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THE immediate and often dramatic improvement in patients with prostatic
cancer, after endocrine treatment, tends to obscure the fact that a relatively
small proportion of cases live for more than 5 years (see Franks, 1958, for review).
The object ofthe present investigation was to see whether there were any specific
features, using routine clinical and pathological methods, by which patients
likely to live for more than 5 years could be recognised at the time of diagnosis.
MATERIAL
There were 32 patients, surviving 5 years or more from the time of diagnosis,
irrespective of the time of first appearance of symptoms, and in 24 of these cases
histological sections from biopsies made at the time of diagnosis were available.
This group was compared with another group from the same series of cases,
living for less than 5 years. There were 53 patients in this latter group, and
26 of these had initial biopsy section available. The whole of this second group
of " short survivors " had come to autopsy and the diagnosis and probable cause
of death were confirmed histologically.
METHODS
From haematoxylin and eosin stained paraffin sections of the initial biopsy
material the tumours were graded, using a similar method to that used in an
earlier investigation (Fergusson and Franks, 1952), and the presence or absence
of basophil (" mucoid ") secretion in the tumour and of a surrounding stromal
reaction, were recorded. Thefollowing clinicalpoints were noted: first symptoms
(urinary or due to metastatic disease), whether the prostate was clinically carcino-
matous on rectal examination, the presence or absence of metastases on radio-
logical examination when first seen, the formal-stable serum acid phosphatase
when first seen, and the cause of death-whether due to prostatic cancer or
intercurrent disease. Changes in the clinical state of the prostate, the serum
acid phosphatase and the later development of metastases were also studied.
The clinical changes in a larger unselected series of cases has been reported in
detail by Fergusson (1958).
RESULTS
The results are shown in detail in Tables I-VI and only the main points will
be discussed below. The number of cases in each group and the percentage of
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TABLE I.-Summary ofRetult8
Age-
50-59
60-69
70-79
80-89
Grade-
High
Average
Low
Not graded
Stromal reaction-
Present
Absent
Ba8ophil 8ecretion-
Present
Absent
First &ymptoma-
Local
Metastatic
Incidental
Initial rectal examnation-
Malignant (+)
Benign (-)
Doubtful (?)
Later rectal examination-
Unchanged
Metawta8ew at dawgo&si-
Present
Paget's disease . .
Absent
Metastases later-
Present
Paget's disease . .
Absent
Serum acidpho8phtaae. Initial-
0 -1 9 K.A. units (Formal-stable)
2*04 49
5*0 or more
Serum acidpho&phatae. Later-
0 -1*9
2-0-4*9
5*0 or more.
Cause ofdeath-
Cancer
Other
Alive or cause ofdeath doubtful
Long survivors
(5 years or more)
Per cent
No.
1
17
10
4
9
9
6
8
of group
3
53
31
13
37
37
25
8 38
13 62
8 40
12 60
28
2
2
24
7
1
10
7
1
14
5
2
25
15
2
15
13
13
3
25
5
0
12
9
11
88
6
6
75
22
3
31
22
3
44
*16
6
78
47
6
47
45
45
10
83
17
57
43
Short survivors
(less than 5 years)
Per cent
No. of group
5 9
12 23
25 47
11 21
15
8
3
27
58
31
11
9 47
10 53
5 26
14 74
39* 72
13* 24
2 4
50
3
0
4
1
0
29
21
3
23
22
1
6
19
11
14
23
9
6
32
18
3
94
6
0
12
3
0
85
45
6
49
76
3
21
43
25
32
60
24
16
64
36
* One patient had symptoms of both local and metastatic disease.
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the group is given but, as in general the numbers are small, the percentages can
only be regarded as a guide for ease of comparison. The apparent discrepancies
in numbers are due to the fact that all investigations were not carried out in a
few cases.
Age (Table I).-The age incidence in both long and short survivors follows the
same general pattern in that most of the cases are between 60 and 80 years of
age. Only one of the six patients between 50 and 60 years lived for more than
5 years. Apart from this the differences in age distribution in the two groups are
probably not significant.
Histological grade (Tables I and II).-In both groups the number of patients
with tumours of a low grade of malignancy is small, but there were more in the
group of long survivors. Although rather more of the short survivors had
high-grade tumours (58 per cent) nearly 40 per cent of the long survivors also
had similar tumours. Thus the survival period is not directly related to the
histological malignancy ofthe tumour. There appears to be no direct association
between histological grade and age (Table II).
TABLE II.-Age and Hi8tological Grade
Long survivors Short survivors
,~~~~ A- - --
High Average Low High Average Low
Age Per Per Per Per Per Per
group No. cent No. cent No. cent No. cent No. cent No. cent
50-59 0 0 0 0 0 0. 4 100 0 0 0 0
60-69. 5 36 7 50 2 14 . 2 33 4 67 0 0
70-79. . 3 37 2 25 3 37 . 4 40 4 40 2 20
80-89. . 1 50 0 0 1 50 5 83 0 0 1 17
All ages . 9 37 9 37 6 25 . 15 58 8 31 3 11
Stromal reaction to the tumour (Table J).-Since it might be thought that a
stromal reaction in the tumour may represent a response by the host to the
tumour, the extent of any fibrous reaction was noted. There are no significant
differences between the groups. It has been suggested that a lymphoid reaction
around the tumour is associated with a long survival period in cancer ofthe breast
(Moore and Foote, 1949) and stomach (Black, Opler and Speer, 1954). However,
in these prostatic tumours a lymphoid reaction was seen only in association with
areas of chronic inflammation, not obviously related to the tumour.
Basophil secretion in the tumours (Table I).-Many well differentiated prostatic
tumours may secrete a basophil mucoid material (Franks, 1954). Since it has
been reported by some workers, e.g. Delbet and Mendaro (1927) and others, that
mucoid secretionin breast tumours was associated with a relativelygood prognosis,
this factor was also assessed. This type of secretion was present more frequently
in the long survivors (40 per cent of cases as compared with 26 per cent), but this
may only reflect the greater number of relatively well differentiated tumours
(average and low grades combined) in this group. (62 per cent as compared with
42 per cent).
First symptoms (Table I).-In both groups the presenting symptoms were
local (urinary) in the great majority but symptoms due to metastasis were
commoner in the short survivors-24 per cent as compared with 6 per cent.L. M. FRANKS, J. D. FERGUSSON AND G. F. MURNAGHAN
Changes on rectal examination (Table 1).-As might be expected almost all
(94 per cent) the short survivors were found to have clinically malignant prostates.
Of the long survivors 75 per cent were clinically malignant but almost a quarter
of the cases (22 per cent) appeared benign. In the course of the disease these all
later developed clinically malignant glands in spite of treatment. In 10 of the
long survivors and 4 of the short survivors the prostate became clinically benign.
This change would seem to be associated with a relatively good prognosis, since
3 of these 4 short survivors died of intercurrent disease (carcinoma of bronchus,
myocardial infarct, chronic intestinal obstruction). The fourth died as a result
of metastatic deposits in the spine.
Metastases, age and histological grade (Tables I-V).-Metastases on radio-
logical examination were absent at the time of diagnosis in nearly 80 per cent
of the long survivors but only in about 50 per cent of the short survivors. This
association-one to be expected-has been noted by many previous writers,
e.g. Bumpus, 1926; Nesbit and Baum, 1950. The presence of Paget's disease
of bone on radiological examination has been noted separately since diffuse
fibrosing metastatic deposits ofprostatic carcinoma may produce this appearance
(Willis 1953; Franks, 1956a). The fact that relatively few patients over the
age of eighty develop metastases (Franks, 1956a) is again confirmed. Secondary
deposits appeared later in 10 of the 25 long survivors (40 per cent) who had no
metastases at the time of diagnosis. All were less than 80 years old (Table III).
TABLE III.-Age and Metastases
Long survivors
--- -N Short survivors
Metastases , -
No developed No
Meta,stases metastases later Metastases metastases
Age Per Per Per Per Per
group No. cent No. cent No. cent No. cent No. cent
50-59. . 0 0 1 100 1 100 . 3 75 1 25
60-69. . 1 6 15 94 5 33 6 55 5 45
70-79. . 3 33 6 67 4 67 11 55 9 45
80-89. . 1 25 3 75 0 0 1 11 8 89
All ages . 5 17 25 83 10 40 21 48 23 52
Only one of the 21 short survivors with metastases was over this age. Similarly
none of the 15 patients (in both groups) who were first presented with symptoms
due to metastases was over 80 (Table IV).
TABLE IV.-Age and First Symptoms
Long survivors Short survivors
Local Metastatic Other Local Metastatic Other
Age Per Per Per Per Per Pei
group No. cent No. cent No. cent No. cent No. cent No. cent
50-59 . 1 100 0 0 0 0 . 2 40 2 40 1 20
60-69 . 15 88 1 6 1 6 . 9 75 3 25 0 0
70-79 . 8 80 1 10 1 10 . 18 69 8 31 0 0
80-89 . 4 100 0 0 0 0 . 10 91 0 0 1 9
All ages. 28 88 2 6 2 6 . 39 72 13 24 2 4
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Among the short survivors there appeared to be some association between
metastases and histological grade, metastases being found more frequently in
patients with more anaplastic tumours, although unexpectedly, the incidence was
higher in those with average grade tumours than in those with high grade tumours
(Table V). Among the long survivors, however, those with low grade tumours
TABLE V.-Hi8tological Grade and Metastase8
Long survivors Short survivors
No No.
Metastases metastases Metastases metastases
Per Per Per Per
Grade No. cent No. cent No. cent No. cent Grade
High 9 1 11 8 89 . 7 47 8 53 . 25 High
Average 9 . 1 11 8 89 . 6 75 2 25 . 8 Average
Low 6 . 2 33 4 67 0 0 3 100 . 3 Low
had a larger proportion with metastases than those with histologically more
malignant tumours. Thus the histological malignancy of the primary tumour
does not necessarily influence the incidence of metastases.
Age and cau8e of death (Table VI).-In both groups the majority of patients
died ofprostatic cancer but a considerable number died from intercurrent disease,
TABLE VI.-Age and Cau8e ofDeath
Long survivors Short survivors
, s~~- A 5 A-
Cancer Other Doubtful Cancer Other Doubtful
Age Per Per Per Per Per Per
group No. cent No. cent No. cent No. cent No. cent No. cent
50-59. 0 0 0 0 0 0 . 4 80 1 20 0 0
60-69. . 7 70 3 30 0 0 . 10 83 2 17 0 0
70-79. 3 43 4 57 0 0 . 15 60 9 36 1 4
80-89. . 2 50 2 50 0 0 3 27 6 55 2 18
All ages .12 57 9 43 0 0. 32 60 18 34 3 6
particularly the older men. The younger the patient, the greater the proportion
dying as a result of cancer.
Serum acid phosphatase (Table J).-The serum phosphatase was higher (over
5*0 units) in alargerproportion ofshort survivors, andremained so aftertreatment.
Benign nodular hyperplasia and prostatic cancer.-Patients with prostatic
carcinomas found after prostatectomy, in men with clinically benign prostatic
enlargement, tend to have a long survival period (Nesbit and Baum, 1951;
Edwards, 1955; Franks, 1956b). In the series of cases reported here there were
5 such patients among the 32 long survivors (16 per cent) but only 1 (who died
from a myocardial infarct) (2 per cent) among the 53 short survivors. One of
the long survivors was found to have developed a carcinoma 6 months after a
retropubic prostatectomy for benign enlargement. Two of the short survivors
had a perurethral resection and one a retropubic prostatectomy for benign
enlargement, 4 years, 2 years and 1J years, respectively, before the carcinoma
was diagnosed.
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SUMMARY AND CONCLUSIONS
The number of patients studied are too few to allow a statistical analysis of
results but in general, it can be said that there is no single feature which is
constantly associated with long survival. The commonest finding in the long
survivors was the absence of metastases at the time of diagnosis (78 per cent)
but as almost half (49 per cent) the short survivors also had no metastases this is
of little value in assessing prognosis in the individual case. A change in the
prostate after treatment from clinically malignant to clinically benign generally
implies a good prognosis but even here death due to the effects of metastatic
deposits is not excluded. A high serum acid phosphatase level (more than
5 formal-stable King-Armstrong units) remaininghighaftertreatment, is generally
associated with a short survival period. The histological grade of the tumour
does not seem to influence the survival of the patient, or the incidence of meta-
stases. Metastases are much less common in the elderly, i.e. men over 80 years
old.
These findings emphasize the need for a reliable method of assessing the
biological malignancy ofprostatic cancer.
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